The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein
Open accessAbstract
High mobility group box 1 (HMGB1) protein, originally described as a DNA-binding protein that stabilizes nucleosomes and facilitates transcription, can also be released extracellularly during acute inflammatory responses. Exposure of neutrophils, monocytes, or macrophages to HMGB1 results in increased nuclear translocation of NF-kappaB and enhanced expression of proinflammatory cytokines. Although the receptor for advanced glycation end products (RAGE) has been shown to interact with HMGB1, other putative HMGB1 receptors are known to exist but have not been characterized. In the present experiments, we explored the role of RAGE, Toll-like receptor (TLR) 2, and TLR 4, as well as associated kinases, in HMGB1-induced cellular activation. Culture of neutrophils or macrophages with HMGB1 produced activation of NF-kappaB through TLR 4-independent mechanisms. Unlike lipopolysaccharide (LPS), which primarily increased the activity of IKKbeta, HMGB1 exposure resulted in activation of both IKKalpha and IKKbeta. Kinases and scaffolding proteins downstream of TLR 2 and TLR 4, but not TLR/interleukin-1 receptor (IL-1R)-independent kinases such as tumor necrosis factor receptor-associated factor 2, were involved in the enhancement of NF-kappaB-dependent transcription by HMGB1. Transfections with dominant negative constructs demonstrated that TLR 2 and TLR 4 were both involved in HMGB1-induced activation of NF-kappaB. In contrast, RAGE played only a minor role in macrophage activation by HMGB1. Interactions of HMGB1 with TLR 2 and TLR 4 may provide an explanation for the ability of HMGB1 to generate inflammatory responses that are similar to those initiated by LPS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Self-citationTakeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,362
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
MyD88 Is an Adaptor Protein in the hToll/IL-1 Receptor Family Signaling Pathways
Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C., Ghosh, S., & Janeway, C. A. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80136-7 · Cited by 1,575
Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)
Qureshi, S. T., Larivière, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P., & Malo, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.615 · Cited by 1,525
Cited by
Items 101–173 of 173
Innate immune signaling in cardiac ischemia
Arslan, F., de Kleijn, D. P., & Pasterkamp, G. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.38 · Cited by 347
Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity
Donath, M. Y., Dalmas, É., Sauter, N. S., & Böni-Schnetzler, M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.001 · Cited by 338
Guijarro-Muñoz, I., Compte, M., Álvarez-Cienfuegos, A., Álvarez-Vallina, L., & Sanz, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.521161 · Cited by 342
High-mobility group box 1 (HMGB1) protein: Friend and foe
ULLOA, L., & MESSMER, D. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.01.003 · Cited by 341
HMGB1: guiding immunity from within
Dumitriu, I. E., Baruah, P., Manfredi, A. A., Bianchi, M. E., & Rovere-Querini, P. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.009 · Cited by 340
Toll-like receptors as targets in chronic liver diseases
Mencin, A., Kluwe, J., & Schwabe, R. F. (2009) · Gut · doi:10.1136/gut.2008.156307 · Cited by 329
Toll-like receptors in inflammation, infection and cancer
Chen, K., Huang, J., Gong, W., Iribarren, P., Dunlop, N. M., & Wang, J. M. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.05.016 · Cited by 327
Clearance of apoptotic and necrotic cells and its immunological consequences
Krysko, D. V., D’Herde, K., & Vandenabeele, P. (2006) · Apoptosis · doi:10.1007/s10495-006-9527-8 · Cited by 316
“case for LPS [125].”
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis
Guo, J., & Friedman, S. L. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-21 · Cited by 311
Inflammation in epilepsy: Clinical observations
Aronica, E., & Crino, P. B. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03033.x · Cited by 306
“For example, within 24 h after tonic–clonic seizure some patients had increased CSF concentrations of IL-6, which was mirrored in plasma (Peltola et al., 1998).”
BackgroundDisulfide HMGB1 derived from platelets coordinates venous thrombosis in mice
Stark, K., Philippi, V., Stockhausen, S., Busse, J., Antonelli, A., Miller, M., Schubert, I., Hoseinpour, P., Chandraratne, S., von Brühl, M.-L., et al. (2016) · Blood · doi:10.1182/blood-2016-04-710632 · Cited by 305
EMERGING PARADIGM: TOLL-LIKE RECEPTOR 4-SENTINEL FOR THE DETECTION OF TISSUE DAMAGE
Mollen, K. P., Anand, R. J., Tsung, A., Prince, J. M., Levy, R. M., & Billiar, T. R. (2006) · Shock · doi:10.1097/01.shk.0000228797.41044.08 · Cited by 305
RAGE (receptor for advanced glycation end products): a central player in the inflammatory response
Chavakis, T., Bierhaus, A., & Nawroth, P. P. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.08.004 · Cited by 301
Hemorrhagic Shock Induces NAD(P)H Oxidase Activation in Neutrophils: Role of HMGB1-TLR4 Signaling
Fan, J., Li, Y., Levy, R. M., Fan, J. J., Hackam, D. J., Vodovotz, Y., Yang, H., Tracey, K. J., Billiar, T. R., & Wilson, M. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6573 · Cited by 299
NF‐κB and cancer: Mechanisms and targets
Karin, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20217 · Cited by 298
High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells
Chavakis, E., Hain, A., Vinci, M., Carmona, G., Bianchi, M. E., Vajkoczy, P., Zeiher, A. M., Chavakis, T., & Dimmeler, S. (2007) · Circulation Research · doi:10.1161/01.res.0000257774.55970.f4 · Cited by 298
Role of Lymphocytes in Myocardial Injury, Healing, and Remodeling After Myocardial Infarction
Hofmann, U., & Frantz, S. (2015) · Circulation Research · doi:10.1161/circresaha.116.304072 · Cited by 296
The innate immune response in reperfused myocardium
Timmers, L., Pasterkamp, G., de Hoog, V. C., Arslan, F., Appelman, Y., & de Kleijn, D. P. V. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs018 · Cited by 291
Willingham, S. B., Bergstralh, D. T., O'Connor, W., Morrison, A. C., Taxman, D. J., Duncan, J. A., Barnoy, S., Venkatesan, M. M., Flavell, R. A., Deshmukh, M., et al. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.07.009 · Cited by 290
Hreggvidsdottir, H. S., Östberg, T., Wähämaa, H., Schierbeck, H., Aveberger, A.-C., Klevenvall, L., Palmblad, K., Ottosson, L., Andersson, U., & Harris, H. E. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0908548 · Cited by 290
TLR-Dependent Human Mucosal Epithelial Cell Responses to Microbial Pathogens
McClure, R., & Massari, P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00386 · Cited by 287
The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?
Gregory, C. D., & Devitt, A. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01959.x · Cited by 285
Molecular Targets Underlying the Anticancer Effects of Quercetin: An Update
Khan, F., Niaz, K., Maqbool, F., Ismail Hassan, F., Abdollahi, M., Nagulapalli Venkata, K., Nabavi, S., & Bishayee, A. (2016) · Nutrients · doi:10.3390/nu8090529 · Cited by 282
Youn, J. H., Oh, Y. J., Kim, E. S., Choi, J. E., & Shin, J.-S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.5067 · Cited by 281
Alarmin(g) news about danger: Workshop on Innate Danger Signals and HMGB1
Harris, H. E., & Raucci, A. (2006) · EMBO reports · doi:10.1038/sj.embor.7400759 · Cited by 277
Srikrishna, G., & Freeze, H. H. (2009) · Neoplasia · doi:10.1593/neo.09284 · Cited by 275
Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
Hirsova, P., Ibrabim, S. H., Gores, G. J., & Malhi, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066357 · Cited by 270
Toll-like Receptors in the Vascular System: Sensing the Dangers Within
Goulopoulou, S., McCarthy, C. G., & Webb, R. C. (2016) · Pharmacological Reviews · doi:10.1124/pr.114.010090 · Cited by 263
van Zoelen, M. A. D., Yang, H., Florquin, S., Meijers, J. C. M., Akira, S., Arnold, B., Nawroth, P. P., Bierhaus, A., Tracey, K. J., & Poll, T. V. D. (2009) · Shock · doi:10.1097/shk.0b013e318186262d · Cited by 262
Shirato, K., & Kizaki, T. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06187 · Cited by 262
Saturated Fatty Acids Do Not Directly Stimulate Toll-Like Receptor Signaling
Erridge, C., & Samani, N. J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.194050 · Cited by 260
Jiménez-Dalmaroni, M. J., Gerswhin, M. E., & Adamopoulos, I. E. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.08.009 · Cited by 259
RAGE and TLRs: Relatives, friends or neighbours?
Ibrahim, Z. A., Armour, C. L., Phipps, S., & Sukkar, M. B. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.07.008 · Cited by 257
Oxidative stress-mediated HMGB1 biology
Yu, Y., Tang, D., & Kang, R. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00093 · Cited by 256
Innate immunity, macrophage activation, and atherosclerosis
Yan, Z., & Hansson, G. K. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00554.x · Cited by 256
Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
Jube, S., Rivera, Z. S., Bianchi, M. E., Powers, A., Wang, E., Pagano, I., Pass, H. I., Gaudino, G., Carbone, M., & Yang, H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3481 · Cited by 255
Antoine, D. J., Williams, D. P., Kipar, A., Jenkins, R. E., Regan, S. L., Sathish, J. G., Kitteringham, N. R., & Park, B. K. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp235 · Cited by 223
MFG-E8 Mediates Primary Phagocytosis of Viable Neurons during Neuroinflammation
Fricker, M., Neher, J. J., Zhao, J.-W., Théry, C., Tolkovsky, A. M., & Brown, G. C. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4837-11.2012 · Cited by 218
Weber, M. D., Frank, M. G., Tracey, K. J., Watkins, L. R., & Maier, S. F. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3561-14.2015 · Cited by 215
Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin)
Rouhiainen, A., Tumova, S., Valmu, L., Kalkkinen, N., & Rauvala, H. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306200 · Cited by 214
Unlocking the biology of RAGE in diabetic microvascular complications
Manigrasso, M. B., Juranek, J., Ramasamy, R., & Schmidt, A. M. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.08.002 · Cited by 209
Activation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development
Zurolo, E., Iyer, A., Maroso, M., Carbonell, C., Anink, J. J., Ravizza, T., Fluiter, K., Spliet, W. G. M., van Rijen, P. C., Vezzani, A., et al. (2011) · Brain · doi:10.1093/brain/awr032 · Cited by 207
“There were no significant differences in TLR2 and TLR4 between focal cortical dysplasia, tuberous sclerosis complex and gangliogliomas.”
BackgroundInfluentialCell Death in Chondrocytes, Osteoblasts, and Osteocytes
Komori, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122045 · Cited by 176
High‐mobility group box‐1 in sterile inflammation
Tsung, A., Tohme, S., & Billiar, T. R. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12276 · Cited by 187
Vetreno, R. P., & Crews, F. T. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.046 · Cited by 183
Toll-like Receptors in Defense and Damage of the Central Nervous System
Aravalli, R. N., Peterson, P. K., & Lokensgard, J. R. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9071-5 · Cited by 173
“Other studies conducted along similar lines demonstrated that heat shock proteins and HMGB1 act as ligands for both TLR2 and TLR4 (Vabulas et al. 2002a, b; Park et al. 2004; Yu et al. 2006).”
BackgroundInfluentialPattern recognition receptors in the immune response against dying cells
Jeannin, P., Jaillon, S., & Delneste, Y. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.04.013 · Cited by 165
HMGB1 Regulates RANKL-Induced Osteoclastogenesis in a Manner Dependent on RAGE
Zhou, Z., Han, J.-Y., Xi, C.-X., Xie, J.-X., Feng, X., Wang, C.-Y., Mei, L., & Xiong, W.-C. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080234 · Cited by 160
Danger‐associated molecular patterns ( DAMPs ) in acute lung injury
Tolle, L. B., & Standiford, T. J. (2013) · The Journal of Pathology · doi:10.1002/path.4124 · Cited by 157
Hemorrhagic Shock Activation of NLRP3 Inflammasome in Lung Endothelial Cells
Xiang, M., Shi, X., Li, Y., Xu, J., Yin, L., Xiao, G., Scott, M. J., Billiar, T. R., Wilson, M. A., & Fan, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102093 · Cited by 155
Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization
Cunha, C., Gomes, C., Vaz, A. R., & Brites, D. (2016) · Mediators of Inflammation · doi:10.1155/2016/6986175 · Cited by 153
“The majority of the studies have reported HMGB1 effects on macrophages and microglia activation [18, 54], but only a few report its increased expression in activated microglia, both in the postischemic brain [55] and in the reactive primary microglia cultures [39].”
CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns
Liu, Y., Chen, G.-Y., & Zheng, P. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.09.006 · Cited by 147
The Alarmin HMGB1 Mediates Age-Induced Neuroinflammatory Priming
Fonken, L. K., Frank, M. G., Kitt, M. M., D'Angelo, H. M., Norden, D. M., Weber, M. D., Barrientos, R. M., Godbout, J. P., Watkins, L. R., & Maier, S. F. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1161-16.2016 · Cited by 139
Toll‐like receptors and pregnancy: Trophoblast as modulators of the immune response
Koga, K., Aldo, P. B., & Mor, G. (2009) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2008.00963.x · Cited by 130
Emerging Roles for HMGB1 Protein in Immunity, Inflammation, and Cancer
Ranzato, E., Martinotti, S., & Patrone, M. (2015) · ImmunoTargets and Therapy · doi:10.2147/itt.s58064 · Cited by 127
“A C-terminal region of HMGB1 at amino acids 150–183 mediates the receptor for advanced glycation end-product (RAGE) and Toll-like receptor (TLR) binding.(13) The RAGE is a cell-bound receptor of the immunoglobulin superfamily that is activated by a variety of proinflammatory ligands, including HMGB1, advanced glycatio…”
Bianchi, M. E., & Manfredi, A. A. (2009) · Science · doi:10.1126/science.1172794 · Cited by 117
Key Aging-Associated Alterations in Primary Microglia Response to Beta-Amyloid Stimulation
Caldeira, C., Cunha, C., Vaz, A. R., Falcão, A. S., Barateiro, A., Seixas, E., Fernandes, A., & Brites, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00277 · Cited by 117
Izuishi, K., Tsung, A., Jeyabalan, G., Critchlow, N. D., Li, J., Tracey, K. J., Demarco, R. A., Lotze, M. T., Fink, M. P., Geller, D. A., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7154 · Cited by 116
RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication
Yamamoto, Y., & Yamamoto, H. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00105 · Cited by 99
Weber, M. D., Frank, M. G., Sobesky, J. L., Watkins, L. R., & Maier, S. F. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.03.004 · Cited by 93
Prantner, D., Nallar, S., & Vogel, S. N. (2020) · The FASEB Journal · doi:10.1096/fj.202002136r · Cited by 92
Holmlund, U., Wähämaa, H., Bachmayer, N., Bremme, K., Sverremark‐Ekström, E., & Palmblad, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02662.x · Cited by 83
HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17‐cell expansion
Su, Z., Sun, C., Zhou, C., Liu, Y., Zhu, H., Sandoghchian, S., Zheng, D., Peng, T., Zhang, Y., Jiao, Z., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141879 · Cited by 81
Acute Brain Injury Triggers MyD88-Dependent, TLR2/4-Independent Inflammatory Responses
Koedel, U., Merbt, U. M., Schmidt, C., Angele, B., Popp, B., Wagner, H., Pfister, H.-W., & Kirschning, C. J. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060821 · Cited by 78
Min, H., Hong, J., Cho, I.-H., Jang, Y. H., Lee, H., Kim, D., Yu, S.-W., Lee, S., & Lee, S. J. (2015) · Molecular Brain · doi:10.1186/s13041-015-0116-z · Cited by 76
“Recent studies have shown that TLR2 functions as a receptor not only for pathogen-associated molecular patterns, but also for endogenous molecules released from damaged tissues or cells, such as heat shock proteins (HSPs) [12-14], hyaluronan [15], soluble CD14 [16] and high mobility group box-1 (HMGB-1) [17,18].”
BackgroundProphylactic and therapeutic implications of toll-like receptor ligands
Hedayat, M., Takeda, K., & Rezaei, N. (2012) · Medicinal Research Reviews · doi:10.1002/med.20214 · Cited by 76
Luan, Z.-G., Zhang, X.-J., Yin, X.-H., Ma, X.-C., Zhang, H., Zhang, C., & Guo, R.-X. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.04.013 · Cited by 59
Targeting HMGB1 TLR4 signaling as a novel approach to treatment of cerebral ischemia
Yang, Q.-W. (2010) · Frontiers in Bioscience · doi:10.2741/s119 · Cited by 55
Alarmins in chronic noncommunicable diseases: Atherosclerosis, diabetes and cancer
Boteanu, R. M., Suica, V. I., Uyy, E., Ivan, L., Dima, S. O., Popescu, I., Simionescu, M., & Antohe, F. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2016.11.006 · Cited by 38
Rouillard, M. E., Hu, J., Sutter, P. A., Kim, H. W., Huang, J. K., & Crocker, S. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.833186 · Cited by 35
Su, Z., Yin, J., Wang, T., Sun, Y., Ni, P., Ma, R., Zhu, H., Zheng, D., Shen, H., Xu, W., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12324 · Cited by 33
Kalkman, H. O. (2023) · Biomedicines · doi:10.3390/biomedicines11030806 · Cited by 18
Metadata
- Authors
- Park, J. S., Svetkauskaite, D., He, Q., Kim, J.-Y., Strassheim, D., Ishizaka, A., & Abraham, E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 279
- Issue
- 9
- Pages
- 7370-7377
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2061163173
- Cited by
- 1,562
- References
- 66
- FWCI
- 22.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.